FDA Warning Letters for Misbranding Cannabinoid Products as Dietary Supplement on the Rise – Bella Rose Labs
0
By
In Dietary Supplements (Claims and Labeling)
Posted

FDA Warning Letters for Misbranding Cannabinoid Products as Dietary Supplement on the Rise – Bella Rose Labs

FDA issues warning letter to New York manufacturer for CBD claims that indicates its products are new drugs and do not qualify as dietary supplements

READ MORE
 June Roundup of FDA and FTC Warning Letters To Healthcare Companies Claiming COVID 19 Treatments and Cures
0
By
In Healthcare Law
Posted

June Roundup of FDA and FTC Warning Letters To Healthcare Companies Claiming COVID 19 Treatments and Cures

The Federal Trade Commission (FTC) and Federal Drug Administration (FDA) are continuing to send warning letters to companies that promise treatments and cures for COVID-19

READ MORE